Kymera Therapeutics, Inc. Share Price
KYMRKymera Therapeutics, Inc. Stock Performance
Open $78.52 | Prev. Close $79.06 | Circuit Range N/A |
Day Range $77.32 - $79.79 | Year Range $19.45 - $102.81 | Volume 38,590 |
Average Traded $79.29 |
Kymera Therapeutics, Inc. Share Price Chart
About Kymera Therapeutics, Inc.
Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase II clinical trial for the treatment of immunology-inflammation diseases, including hidradenitis suppurativa and atopic dermatitis. The company also develops STAT6, a type 2 inflammation in allergic and atopic diseases; and TYK2 to treat autoimmune and inflammatory diseases. The company has a strategic alliance with Sanofi S.A. for the development of drug candidates targeting IRAK4 outside of the oncology and immuno-oncology fields. Kymera Therapeutics, Inc. was incorporated in 2015 and is headquartered in Watertown, Massachusetts.
Kymera Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
06-Feb-26 | $78.52 | $79.62 | +4.78% |
05-Feb-26 | $76.31 | $75.99 | -2.18% |
04-Feb-26 | $76.34 | $77.68 | +0.50% |
03-Feb-26 | $76.05 | $77.29 | +2.05% |
02-Feb-26 | $71.60 | $75.74 | +4.20% |
30-Jan-26 | $73.95 | $72.69 | -1.54% |
29-Jan-26 | $71.22 | $73.83 | +3.72% |
FAQs on Kymera Therapeutics, Inc. Share Price
Can I buy Kymera Therapeutics, Inc. shares in India?
What is the share price of Kymera Therapeutics, Inc.?
What is the 5 year returns of Kymera Therapeutics, Inc.?
What are the high & low stock price of Kymera Therapeutics, Inc. today?
What is the 52-week high and low of Kymera Therapeutics, Inc. stock?